Source: American Academy of Family Physicians
In this episode of Inside Family Medicine, sponsored by Roche Diagnostics, host Darren Sextro talks with brain health experts Deanna Willis, MD, MBA, a board-certified family physician, and Jared Brosch, MD, board-certified neurologist, on the use of blood-based biomarkers (BBBMs) in primary care settings for Alzheimer’s disease and related dementias.
Their discussion explores how BBBMs can make referrals more efficient and enhance the evaluation of patients with cognitive decline. The conversation highlights the value of early diagnosis and therapy referrals as well as outlines effective workflow strategies for primary care teams.
Additional Resources
- Roche Diagnostics Elecsys Phospho-Tau (181P) Plasma decision summary
- 2024 CEOi recommendations for clinical implementation of blood-based biomarkers for Alzheimer’s disease
- 2025 Alzheimer’s Association clinical guidelines for primary care
- Implementing early detection of cognitive impairment in primary care to improve care for older adults
- Blood Biomarkers and Early Detection of Alzheimer’s Disease and Related Dementias
- Brain health resources for patients from the AAFP
Listen today!